BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
24 results:

  • 1. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
    Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
    Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.
    Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T
    Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. USP10 suppresses abcg2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
    Sun J; Xiang Q; Ding D; Yan N
    J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced thyroid cancer.
    Cantara S; Dalmiglio C; Marzocchi C; Sagnella A; Brilli L; Trimarchi A; Maino F; Valerio L; Castagna MG
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982571
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells.
    Latar NM; Mahkamova K; Elson J; Karnik I; Sutherland R; Aspinall S; Meeson A
    Endocrine; 2022 May; 76(2):359-368. PubMed ID: 35118633
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast cancer Cell Lines MDA-MB-453 and MCF-7.
    Terasaki A; Kurokawa H; Ito H; Komatsu Y; Matano D; Terasaki M; Bando H; Hara H; Matsui H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333736
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
    Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
    Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Case of Hashimoto's thyroiditis with Multiple Drug Resistance and High Expression of Efflux Transporters.
    Yoshida T; Nakayama A; Tamura A; Higuchi S; Sakuma I; Nagano H; Felizola SJ; Hashimoto N; Takemoto M; Tatsuno I; Koide H; Yokote K; Tanaka T
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614366
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic thyroid cancer: A Systematic Review.
    Abbasifarid E; Sajjadi-Jazi SM; Beheshtian M; Samimi H; Larijani B; Haghpanah V
    Endocrinology; 2019 Aug; 160(8):2015-2023. PubMed ID: 31271419
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
    Ozeki T; Nagahama M; Fujita K; Suzuki A; Sugino K; Ito K; Miura M
    Sci Rep; 2019 Apr; 9(1):5404. PubMed ID: 30931962
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
    Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
    Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
    Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
    Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering abcg2 expression.
    Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic thyroid cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Modulating the function of ATP-binding cassette subfamily G member 2 (abcg2) with inhibitor cabozantinib.
    Zhang GN; Zhang YK; Wang YJ; Barbuti AM; Zhu XJ; Yu XY; Wen AW; Wurpel JND; Chen ZS
    Pharmacol Res; 2017 May; 119():89-98. PubMed ID: 28131876
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
    Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
    Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Expression of abcg2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
    Qu H; Fang L; Duan L; Long X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
    Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
    Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.